AIM continues to shrink, but….
We raise a glass to AIM’s newest arrival, which comes with some attractive shareholder benefits. Hopefully it will encourage others to join. (Free to read)
The number of companies on AIM continue to fall. October and November didn’t see any new admissions, but a total of 18 cancellations, including several excellent and substantial companies. At the end of November 2023, the value of AIM had fallen to £72 billion across 769 companies, an average value of £94m per company. This compares to a total value of £93.2 billion across 816 companies at the end of 2022, an average value of £114m per company. There have been two significant leavers from the healthcare sector in recent months. November saw the departure of Ergomed, which was acquired…